Understanding the complex hormonal science behind weight loss injections - and why they must remain strictly ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Novo Nordisk ( ($NVO) ) has risen by 10.56%. Read on to learn why. Novo Nordisk has seen a notable increase in its stock price, rising by 10.56% ...

Weight loss pills either reduce appetite, boost metabolism or block fat absorption. Most people lose 5% to 10% of their body ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

SHOPPING: If you're ready to meet your weight goals, turn to Hims for personalized weight loss treatments that are ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...